TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Aardvark Therapeutics, Inc. (NASDAQ: AARD) Investor Securities Class Action Lawsuit 08/14/2026

  • If you purchased a significant amount of shares of Aardvark Therapeutics, Inc. (NASDAQ: AARD) connection with the Company’s initial public offering conducted on or about February 13, 2025 (the “IPO” or “Offering”); and/or (b) Aardvark securities between February 13, 2025 and May 14, 2026, and / or if you purchased any NASDAQ: AARD shares in February 2025 or shortly thereafter and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 13, 2026. NASDAQ: AARD investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 14, 2026 - An investor in shares of Aardvark Therapeutics, Inc. (NASDAQ: AARD) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by Aardvark Therapeutics, Inc. in connection with certain allegedly false and misleading statements made in connection with the Company’s initial public offering condu...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)